Browsing by Author Wittawatmongkol O.

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)
2012High virologic response rate after second-line boosted protease inhibitor-based antiretroviral therapy regimens in children from a resource limited settingPuthanakit T.; Jourdain G.; Suntarattiwong P.; Chokephaibulkit K.; Siangphoe U.; Suwanlerk T.; Prasitsuebsai W.; Sirisanthana V.; Kosalaraksa P.; Petdachai W.; Hansudewechakul R.; Waranawat N.; Ananworanich J.; Bunupuradah T.; Phasomsap C.; Kaew-on P.; Kanjanavanit S.; Hinjiranandana T.; Layangool P.; Kamonpakorn N.; Buranabanjasatean S.; Ngampiyaskul C.; Chotpitayasunondh T.; Chanpradub S.; Leawsrisuk P.; Chearskul S.; Vanprapar N.; Phongsamart W.; Lapphra K.; Chearskul P.; Wittawatmongkol O.; Intalapaporn K.; Kongstan N.; Pannin N.; Maleesatharn A.; Khumcha B.; Aurpibul L.; Wongnum N.; Nadsasarn R.; Lumbiganon P.; Tharnprisan P.; Udompanich T.; Yentang M.; Khonponoi A.; Maneerat N.; Denjunta S.; WatanapornS.; Yodsuwan C.; Srisuk W.; Somsri S.; Surapanichadul K.
2011Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai childrenPhongsamart W.; Sirisanthana V.; Wittawatmongkol O.; Maleesatharn A.; Sudjaritruk T.; Chearskul P.; Aurpibul L.; Sirisanthana T.; Chokephaibulkit K.
2012Once- versus twice-daily lopinavir/ritonavir tablets in virologically suppressed, HIV-infected, treatment-experienced children: Comparative pharmacokinetics and virological outcome after switching to once-daily lopinavir/ritonavirChokephaibulkit K.; Nuntarukchaikul M.; Phongsamart W.; Wittawatmongkol O.; Lapphra K.; Vanprapar N.; Cressey T.R.
2014Pharmacokinetics and efficacy of darunavir/ritonavir once daily in virologically suppressed, treatment-experienced HIV-infected childrenChokephaibulkit K.; Rungmaitree S.; Phongsamart W.; Lappra K.; Wittawatmongkol O.; Kongstan N.; Cressey T.R.
2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenChokephaibulkit K.; Cressey T.R.; Capparelli E.; Sirisanthana V.; Muresan P.; Hongsiriwon S.; Ngampiyaskul C.; Limwongse C.; Wittawatmongkol O.; Aurpibul L.; Kabat B.; Toye M.; Smith M.E.; Eksaengsri A.; McIntosh K.; Yogev R.
2011Pharmacokinetics and safety of a new paediatric fixed-dose combination of zidovudine/lamivudine/nevirapine in HIV-infected childrenChokephaibulkit K.; Cressey T.R.; Capparelli E.; Sirisanthana V.; Muresan P.; Hongsiriwon S.; Ngampiyaskul C.; Limwongse C.; Wittawatmongkol O.; Aurpibul L.; Kabat B.; Toye M.; Smith M.E.; Eksaengsri A.; McIntosh K.; Yogev R.